Evidence map›Paper›PMID 35510549›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2022

Perspectives on Cognitive Phenotypes and Models of Vascular Disease.

Selen C Muratoglu, Marc F Charette, Zorina S Galis, Adam S Greenstein, Alan Daugherty, Anne Joutel, Beth A Kozel, Donna M Wilcock, Emily C Collins, Farzaneh A Sorond and 11 more

Open access · greenAbstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Cerebrovascular p16Acta neuropathologica communications · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 5 countries.

Selen C Muratoglu *National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (S.C.M., M.F.C., Z.S.G.).ORCID 0000-0002-1804-4875
Marc F Charette *National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (S.C.M., M.F.C., Z.S.G.).
Zorina S GalisNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (S.C.M., M.F.C., Z.S.G.).ORCID 0000-0001-6686-4766
Adam S GreensteinDivision of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom (A.S.G.).ORCID 0000-0002-5274-4189
Alan DaughertySaha Cardiovascular Research Center (A.D.), University of Kentucky, Lexington.ORCID 0000-0003-2093-3775
Anne JoutelInstitute of Psychiatry and Neurosciences of Paris, INSERM U1266, Université Paris Descartes, France (A.J.).ORCID 0000-0003-3963-3860
Beth A KozelTranslational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (B.A.K., M.B.).ORCID 0000-0002-9757-7118
Donna M WilcockSanders-Brown Center on Aging, Department of Neuroscience (D.M.W.), University of Kentucky, Lexington.
Emily C CollinsEli Lilly and Company, Indianapolis, IN (E.C.C.).
Farzaneh A SorondDivision of Stroke and Neurocritical Care, Northwestern University Feinberg School of Medicine, Chicago, IL (F.A.S.).
Gareth R HowellThe Jackson Laboratory, Bar Harbor, ME (G.R.H.).
Hyacinth I HyacinthDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, OH (H.I.H.).ORCID 0000-0002-1991-7463
Kent K C LloydMutant Mouse Resource and Research Center (MMRRC) at the University of California, Davis (K.K.C.L.).
Kurt R StenmarkDevelopmental Lung Biology and Cardiovascular Pulmonary Research Laboratories, University of Colorado, Denver (K.R.S.).ORCID 0000-0001-6918-6411
Manfred BoehmTranslational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (B.A.K., M.B.).
Mark L KahnDepartment of Medicine and Cardiovascular Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia (M.L.K.).ORCID 0000-0002-6489-7086
Roderick CorriveauNational Institute for Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD (R.C.).
Sara WellsMary Lyon Centre, Harwell Campus, MRC Harwell Institute, Oxfordshire, United Kingdom (S.W.).ORCID 0000-0002-0572-0600
Timothy J BusseyTranslational Neuroscience Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (T.J.B.).
Stacey J Sukoff Rizzo *Department of Medicine-Aging Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA (S.J.S.R.).
M Luisa Iruela-Arispe *Department of Cell and Developmental Biology, Northwestern University, Feinberg School of Medicine, Chicago, IL (M.L.I.-A.).ORCID 0000-0002-3050-4168
National Heart Lung and Blood Institute · USNorthwestern University · USUniversity of Kentucky · USDélégation Paris 5 · FREli Lilly (United States) · USLung Institute · USMaharishi University of Management and Technology · INManchester Academic Health Science Centre · GBMary Lyon Centre at MRC Harwell · GBNational Institute of Neurological Disorders and Stroke · USTufts University · USUniversity of Cincinnati Medical Center · USUniversity of Pennsylvania · USUniversity of Pittsburgh · USWestern University · CA

Funding

University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
Vascular remodeling in patients with rare genetic disordersZIAHL006077 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI BOEHM, MANFRED · 2010 to 2025
$22.9M
iPS-technology and patient specific disease modelsZIAHL006079 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI BOEHM, MANFRED · 2010 to 2025
$14.4M
Role of Complement-Driven Pulmonary Vascular Inflammation in PHP01HL152961 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DELANEY, CASSIDY A · 2020 to 2024
$14.1M
Murine models of vascular remodelingZIAHL006078 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI BOEHM, MANFRED · 2010 to 2025
$11.4M
Williams syndrome: A Translational Approach to Mechanism and TreatmentZIAHL006210 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KOZEL, BETH · 2016 to 2024
$10.4M
Sickle cell disease and the functional circuit of adult-born neurons in the dentate gyrusR01HL156024 · NHLBI · UNIVERSITY OF CINCINNATI · PI HYACINTH, HYACINTH IDU · 2021 to 2025
$4.0M
Mechanism of cerebral vaculopathy and stroke in sickle cell diseaseR01HL138423 · NHLBI · UNIVERSITY OF CINCINNATI · PI HYACINTH, HYACINTH IDU · 2017 to 2021
$2.5M
Cerebral Small Vessels in Motor and Cognitive Decline: Neuroimaging Signatures of Vulnerability & ResilienceRF1NS085002 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SOROND, FARZANEH A · 2022 to 2022
$1.5M
Novel Techniques for Vascular Investigation ZIAHL006247 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KOZEL, BETH · 2020 to 2022
$739k
Intramural NIH HHS Z99 HL999999Medical Research Council MC_UP_1502/1Medical Research Council MC_UP_2201/1NHLBI NIH HHS P01 HL152961NHLBI NIH HHS R01 HL138423NIA NIH HHS P30 AG072946NIMHD NIH HHS L60 MD013112NINDS NIH HHS RF1 NS085002
6 · The paper itself

Abstract

Clinical investigations have established that vascular-associated medical conditions are significant risk factors for various kinds of dementia. And yet, we are unable to associate certain types of vascular deficiencies with specific cognitive impairments. The reasons for this are many, not the least of which are that most vascular disorders are multi-factorial and the development of vascular dementia in humans is often a multi-year or multi-decade progression. To better study vascular disease and its underlying causes, the National Heart, Lung, and Blood Institute of the National Institutes of Health has invested considerable resources in the development of animal models that recapitulate various aspects of human vascular disease. Many of these models, mainly in the mouse, are based on genetic mutations, frequently using single-gene mutations to examine the role of specific proteins in vascular function. These models could serve as useful tools for understanding the association of specific vascular signaling pathways with specific neurological and cognitive impairments related to dementia. To advance the state of the vascular dementia field and improve the information sharing between the vascular biology and neurobehavioral research communities, National Heart, Lung, and Blood Institute convened a workshop to bring in scientists from these knowledge domains to discuss the potential utility of establishing a comprehensive phenotypic cognitive assessment of a selected set of existing mouse models, representative of the spectrum of vascular disorders, with particular attention focused on age, sex, and rigor and reproducibility. The workshop highlighted the potential of associating well-characterized vascular disease models, with validated cognitive outcomes, that can be used to link specific vascular signaling pathways with specific cognitive and neurobehavioral deficits.

Indexed as

Cognitive DysfunctionDementia, VascularAnimalsCognitionMicePhenotypeReproducibility of Resultsatrophyblood pressuremutationrisk factorsvascular dementia

Identifiers

PMID35510549
PMCPMC9233038
OpenAlexW4229030387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.